Mei Pharma Stock In The News

MEIP Stock  USD 2.43  0.03  1.22%   
The analysis of MEI Pharma's news coverage and content from conventional and social sources shows investors' indifference towards MEI Pharma. The specific impact of MEI Pharma news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of MEI Pharma's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using MEI Pharma headlines in addition to utilizing other, more conventional financial analysis modules. Check out MEI Pharma Backtesting and MEI Pharma Hype Analysis.
To learn how to invest in MEI Stock, please use our How to Invest in MEI Pharma guide.

MEI Pharma Today Top News and Investor Outlook

Yahoo News
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
https://finance.yahoo.com/news/7-undervalued-biotech-stocks-buy-181831232.html
 Bullish
Yahoo News
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
https://finance.yahoo.com/news/12-most-undervalued-biotech-stocks-180928477.html
 Bullish
Yahoo News
11 Cheapest Stocks With Biggest Upside
https://finance.yahoo.com/news/11-cheapest-stocks-biggest-upside-153308281.html
 Bullish
Macroaxis News: globenewswire.com
Anson and Cable Car Send Letter to MEI Pharma Stockholders
https://www.globenewswire.com/news-release/2023/10/10/2757724/0/en/Anson-and-Cable-Car-Send-Letter-to-MEI-Pharma-Stockholders.html
 Bullish
Macroaxis News: globenewswire.com
Anson And Cable Car Send Letter to MEI Pharma Stockholders
https://www.globenewswire.com/news-release/2023/09/26/2749919/0/en/Anson-And-Cable-Car-Send-Letter-to-MEI-Pharma-Stockholders.html
 Bullish
Yahoo News
Cambridge biotech cuts most staffers after merger falls apart
https://finance.yahoo.com/m/1cab9926-4ef7-3f2d-b45a-946f210b9401/cambridge-biotech-cuts-most.html
 Neutral
Yahoo News
MEI Pharma Announces Results of Special Meeting of Stockholders
https://finance.yahoo.com/news/mei-pharma-announces-results-special-183000960.html
 Bullish
Yahoo News
MEI Pharma Reminds Shareholders to Vote Today FOR the Infinity Transaction
https://finance.yahoo.com/news/mei-pharma-reminds-shareholders-vote-120000632.html
 Neutral
Yahoo News
MEI Pharma Responds to Anson and Cable Car
https://finance.yahoo.com/news/mei-pharma-responds-anson-cable-130000599.html
 Neutral
Yahoo News
Anson and Cable Car File Preliminary Consent Materials to Remove Entire Board of Directors at MEI Pharma, Inc.
https://finance.yahoo.com/news/anson-cable-car-file-preliminary-131700560.html
 Bullish

MEI Pharma Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide MEI and other traded companies coverage with news coverage. We help investors stay connected with MEI headlines for the 5th of March to make an informed investment decision based on correlating the impacts of news items on MEI Stock performance. Please note that trading solely based on the MEI Pharma hype is not for everyone as timely availability and quick action are needed to avoid losses.
MEI Pharma's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help MEI Pharma investors visualize upcoming and past events in order to time the market based on MEI Pharma noise-free hype analysis.
MEI Pharma stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the MEI earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about MEI Pharma that are available to investors today. That information is available publicly through MEI media outlets and privately through word of mouth or via MEI internal channels. However, regardless of the origin, that massive amount of MEI data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MEI Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MEI Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MEI Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MEI Pharma alpha.

MEI Largest EPS Surprises

Earnings surprises can significantly impact MEI Pharma's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-11-14
2022-09-30-0.14-0.120.0214 
2021-11-10
2021-09-30-0.13-0.110.0215 
2017-05-04
2017-03-31-0.04-0.020.0250 
2013-05-09
2013-03-31-0.2-0.180.0210 
2021-02-04
2020-12-31-0.13-0.10.0323 
2019-02-07
2018-12-31-0.12-0.15-0.0325 
View All Earnings Estimates

MEI Pharma Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to MEI Pharma Stock. Current markets are strongly bearish. About 89% of major world exchanges and indexes are down. See today's market update for more information.
news
3rd of March 2025
Short Interest in MEI Pharma, Inc. Decreases By 27.6
at thelincolnianonline.com 
seekingalpha News
12th of February 2025
MEI Pharma GAAP EPS of -0.40
at seekingalpha.com 
Google News at Macroaxis
16th of December 2024
MEI Pharma stock hits 52-week low at 2.54 amid market challenges - Investing.com
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MEI Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MEI Pharma's short interest history, or implied volatility extrapolated from MEI Pharma options trading.

Additional Tools for MEI Stock Analysis

When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.